# Sumatriptan and Naproxen Sodium

NDC: 65862-928
Generic name: Sumatriptan and Naproxen Sodium
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180215

FDA application: ANDA207457

## Active ingredients

- NAPROXEN SODIUM: 500 mg/1
- SUMATRIPTAN SUCCINATE: 85 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-928"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-928
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5203c66-0a40-4263-a237-b71e930e4697